» Articles » PMID: 28766276

Impact of Membrane Lung Surface Area and Blood Flow on Extracorporeal CO Removal During Severe Respiratory Acidosis

Overview
Specialty Critical Care
Date 2017 Aug 3
PMID 28766276
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Veno-venous extracorporeal CO removal (vv-ECCOR) is increasingly being used in the setting of acute respiratory failure. Blood flow rates through the device range from 200 ml/min to more than 1500 ml/min, and the membrane surface areas range from 0.35 to 1.3 m. The present study in an animal model with similar CO production as an adult patient was aimed at determining the optimal membrane lung surface area and technical requirements for successful vv-ECCOR.

Methods: Four different membrane lungs, with varying lung surface areas of 0.4, 0.8, 1.0, and 1.3m were used to perform vv-ECCOR in seven anesthetized, mechanically ventilated, pigs with experimentally induced severe respiratory acidosis (pH 7.0-7.1) using a 20Fr double-lumen catheter with a sweep gas flow rate of 8 L/min. During each experiment, the blood flow was increased stepwise from 250 to 1000 ml/min.

Results: Amelioration of severe respiratory acidosis was only feasible when blood flow rates from 750 to 1000 ml/min were used with a membrane lung surface area of at least 0.8 m. Maximal CO elimination was 150.8 ml/min, with pH increasing from 7.01 to 7.30 (blood flow 1000 ml/min; membrane lung 1.3 m). The membrane lung with a surface of 0.4 m allowed a maximum CO elimination rate of 71.7 mL/min, which did not result in the normalization of pH, even with a blood flow rate of 1000 ml/min. Also of note, an increase of the surface area above 1.0 m did not result in substantially higher CO elimination rates. The pressure drop across the oxygenator was considerably lower (<10 mmHg) in the largest membrane lung, whereas the smallest revealed a pressure drop of more than 50 mmHg with 1000 ml blood flow/min.

Conclusions: In this porcine model, vv-ECCOR was most effective when using blood flow rates ranging between 750 and 1000 ml/min, with a membrane lung surface of at least 0.8 m. In contrast, low blood flow rates (250-500 ml/min) were not sufficient to completely correct severe respiratory acidosis, irrespective of the surface area of the membrane lung being used. The converse was also true, low surface membrane lungs (0.4 m) were not capable of completely correcting severe respiratory acidosis across the range of blood flows used in this study.

Citing Articles

Recent Advances and Future Directions in Extracorporeal Carbon Dioxide Removal.

Lamas T, Fernandes S, Vasques F, Karagiannidis C, Camporota L, Barrett N J Clin Med. 2025; 14(1.

PMID: 39797096 PMC: 11722077. DOI: 10.3390/jcm14010012.


Factors associated with carbon dioxide transfer in an experimental model of severe acute kidney injury and hypoventilation during high bicarbonate continuous renal replacement therapy and oxygenation membrane support.

Santos Y, Cardozo Junior L, Mendes P, Besen B, Park M Crit Care Sci. 2024; 36:e20240005en.

PMID: 38985048 PMC: 11208041. DOI: 10.62675/2965-2774.20240005-en.


Effects of extracorporeal CO removal on gas exchange and ventilator settings: a systematic review and meta-analysis.

Stommel A, Herkner H, Kienbacher C, Wildner B, Hermann A, Staudinger T Crit Care. 2024; 28(1):146.

PMID: 38693569 PMC: 11061932. DOI: 10.1186/s13054-024-04927-x.


In vitro evaluation of the performance of an oxygenator depending on the non-standard gas content of the inlet blood with special regard on CO2 elimination.

Hima F, Saunders A, Kashefi A, Mouzakis F, Mottaghy K, Spillner J Perfusion. 2023; 39(8):1614-1620.

PMID: 37739434 PMC: 11492679. DOI: 10.1177/02676591231204565.


Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device.

Tiruvoipati R, Ludski J, Gupta S, Subramaniam A, Ponnapa Reddy M, Paul E Eur J Med Res. 2023; 28(1):291.

PMID: 37596670 PMC: 10436516. DOI: 10.1186/s40001-023-01269-2.


References
1.
Abrams D, Roncon-Albuquerque Jr R, Brodie D . What's new in extracorporeal carbon dioxide removal for COPD?. Intensive Care Med. 2015; 41(5):906-8. DOI: 10.1007/s00134-015-3677-5. View

2.
Terragni P, Del Sorbo L, Mascia L, Urbino R, Martin E, Birocco A . Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology. 2009; 111(4):826-35. DOI: 10.1097/ALN.0b013e3181b764d2. View

3.
Williams D, Turi J, Hornik C, Bonadonna D, Williford W, Walczak R . Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis. ASAIO J. 2014; 61(2):190-5. PMC: 4537148. DOI: 10.1097/MAT.0000000000000173. View

4.
Romagnoli S, Ricci Z, Ronco C . Novel Extracorporeal Therapies for Combined Renal-Pulmonary Dysfunction. Semin Nephrol. 2016; 36(1):71-7. DOI: 10.1016/j.semnephrol.2016.01.002. View

5.
Forster C, Schriewer J, John S, Eckardt K, Willam C . Low-flow CO₂ removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care. 2013; 17(4):R154. PMC: 4056563. DOI: 10.1186/cc12833. View